SEC Form 4/A · accession 0001209191-15-006524
ACURA PHARMACEUTICALS, INC · ACUR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owners
GALEN PARTNERS III L P
10% Owner
GALEN PARTNERS INTERNATIONAL III L P
10% Owner
GALEN EMPLOYEE FUND III LP
10% Owner
CLAUDIUS LLC
10% Owner
Galen Management, LLC
10% Owner
Period of report
Jan 8, 2015
Accepted (ET)
Jan 26, 2015 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000786947
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jan 8, 2015 | S | 100,000 | $0.6018 | D | 11,154,497 | I | See FN |
| Common StockF4,F5,F6 | Jan 9, 2015 | S | 36,000 | $0.651 | D | 11,118,497 | I | See FN |
| Common StockF7,F8,F9 | Jan 12, 2015 | S | 35,000 | $0.6416 | D | 11,083,497 | I | See FN |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold as follows: 91,356 by Galen Partners III, L.P. ("Galen III"), 8,268 by Galen Partners International III, L.P. ("Galen International") and 376 by Galen Employee Fund III, L.P. ("Employee Fund").
- F2The shares were sold at prices between $0.59 and $0.621. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The shares are held as follows: 10,193,315 by Galen III, 919,192 by Galen International and 41,990 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
- F4The shares were sold as follows: 32,888 by Galen III, 2,977 by Galen International and 135 by Employee Fund.
- F5The shares were sold at prices between $0.64 and $0.66. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The shares are held as follows: 10,160,427 by Galen III, 916,215 by Galen International and 41,855 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
- F7The shares were sold as follows: 31,974 by Galen III, 2,894 by Galen International and 132 by Employee Fund.
- F8The shares were sold at prices between $0.62 and $0.67. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F9The shares are held as follows: 10,128,453 by Galen III, 913,321 by Galen International and 41,723 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
Remarks
This amendment is being filed to correct the number of shares reported as beneficially owned following the reported transactions.